~" The results of transsphenoidal microsurgery in treating 37 patients (30 women and seven men) with pituitary tumgrs associated with hyperprolactinemia are presented. Immediate (10-day) postoperative fasting prolactin levels were normal (< 25 ng/ml) in 19 of 26 patients whose preaperative prolactin level was < 200 ng/ml, and in only three of 11 patients in whom preoperative prolactin was > 200 ng/ml. Twelve of 13 patients with normal preoperative pituitary-target organ function maintained normal axes postoperatively. Thirteen other patients had preoperative deficiencies in one or more pituitary-target organ axes. Postoperatively, in these latter 13 patients, a pituitary-target organ axis that was deficient preoperatively returned to normal in six cases; there was no change in five, and there was impairment in another axis in four instances. Although gross total tumor removal was believed to be complete in 35 of 37 patients, serial postoperative prolactin determinations in four of these 35 patients indicate tumor regrowth. The authors conclude that transsphenoidal microsurgery is currently the operative procedure of choice for the majority of pituitary tumors associated with hyperprolactinemia.
T HE transseptal, transsphenoidal microsurgical operation appears to be the most appropriate method for the surgical management of pituitary tumors. Chief among the advantages of this operative approach is the capability for complete tumor removal with preservation of the pituitary gland, and a significant reduction in operative mortality and morbidity as compared to other operative approaches, particularly craniotomy. 2,5'~'15-17,25'27,se,s7 Along with the refinements and modifications in the transsphenoidal approach, there have been advances and innovations in endocrinological evaluation techniques and neuroradiological diagnostic procedures, especially the increased use of hypocycloidal polytomography of the sella turcica and the introduction of the computerized tomography (CT) scan. 2,, 85 As a result of these many significant advances both in diagnosis and surgery, neurosurgeons have become more aggressive in their attitude toward treatment of pituitary tumors, and currently are operating on patients for the endocrinopathy as well as the mass effects (such as chiasmal compression) caused by the lesion.
An important advance in endocrinological evaluation that has contributed significantly G. T. Tindall, to the early detection of pituitary tumors is the use of serum prolactin assays. These assays, which include a test for prolactin reserve, have now made it possible to diagnose many small, minimally symptomatic, and previously undetectable pituitary tumors. This report deals with 37 patients with pituitary tumors associated with inappropriate secretion of prolactin, in the majority of whom both the diagnosis and the decision to proceed with transsphenoidal microsurgery were facilitated by the baseline serum prolactin and the test for prolactin reserve. The results of surgery in terms of completeness of tumor removal, preservation of normal (or return to normal) pituitary function, return of abnormal levels of prolactin to normal, and improvement in symptomatology are the subject of this report.
Clinical Material
Over a 4-year period (August, 1973 , to June, 1977) a total of 100 patients with C. S. McLanahan and J. H. Christy pituitary tumors were operated on via the transsphenoidal microsurgical approach at the Emory University Affiliated Hospitals. Of this number, preoperative fasting prolactin determinations were available in 56. Thirty-seven of the 56 cases were associated with hyperprolactinemia and these cases form the basis for this report. In this group there were 30 women and seven men with ages ranging from 16 to 76 years (mean 30 years). Interestingly, in the total series of 100, there were four patients with pituitary tumors (all eosinophilic adenomas) associated with acromegaly who also had elevated fasting values of prolactin ranging from 64 to 150 ng/ml. These four patients are not included in the present report.
All patients underwent a formal protocol of testing for pituitary function before and 10 days after surgery. The tests (Table 1) were believed to be the minimum studies that would provide accurate assessment of general pituitary and pituitary-target organ function.
In testing for prolactin reserve, blood for serum prolactin determination by radioimmunoassay is drawn at 0 time and again at 60, 120, 180, and 240 minutes after intramuscular injection of 50 mg chlorpromazine, a8 The normal basal value ranges from 5 to 25 ng/ml. A less than twofold increase at the peak response after chlorpromazine is considered to show loss of pituitary reserve if the baseline prolactin value is low and loss of hypothalamic control if the baseline is high.
Operative Technique
The operative technique is similar to that described by Hardy. x*,15 The procedure was performed with the patient under general anesthesia. The upper lip was retracted and an incision made in the gingival mucosa. The soft tissues were separated from the maxilla and the mucosa of the nasal passage exposed. A submucosal dissection plane was developed along the left side of the nasal septum. With this technique, the septum remains intact except posteriorly. The thin bony septum near the anterior wall of the sphenoid sinus was fractured. Insertion and opening of the speculum pushes the mucosa away from the anterior wall of the sphenoid on both sides. The anterior wall of the sphenoid sinus was removed. With the aid of televised fluoroscopy, the limits of the floor of the sella tur-cica were identified. The operating microscope was then brought into the surgical field and the remainder of the operation performed under magnification.
Since many tumors associated with abnormalities in prolactin secretion are small, often no larger than 5 mm in diameter, it is important not to damage the pituitary gland during the dural opening. Lacerations in the gland with small amounts of subcapsular bleeding makes it extremely difficult, if not impossible, to detect the subtle differences that exist between normal gland and small tumors (microadenomas --pituitary adenomas < 1 cm in greatest diameter) and that must be determined if the surgeon is to successfully remove the tumor and spare the gland. Also, the less the gland is manipulated the greater the chance for preservation of pituitary function postoperatively. The dura mater can be opened safely by making a slow, deliberate incision with a No. 11 blade on an appropriate bayonet knife holder under relatively high magnification (objective setting at 25 on the Zeiss microscope using a X 12.5 eyepiece and a 300-mm lens). Once an adequate opening is made, it can be enlarged appropriately with fine angled microscissors. The prolactin microadenomas were always laterally situated in the gland. Larger pituitary tumors enlarged and usually eroded the floor of the sella turcica, and in these cases tumor commonly extruded into the operative wound upon removing the floor of the sella and opening the dura mater. Frequently, the pituitary gland was compressed and flattened against the dorsum sellae or diaphragma sellae by the tumor. After total or subtotal removal of the tumor, absolute alcohol was applied to the tumor bed for 2 minutes. Alcohol was used only when the diaphragma sellae-tumor capsule was intact, thus forming a barrier between the subarachnoid space and the tumor site.
Adipose tissue taken from the abdominal wall was inserted loosely into the tumor bed to prevent prolapse of the optic chiasm into the sella turcica. Closure of the wound was simple and involved one to two catgut sutures in the gingival mucosa. Soft airway tubes were inserted into each nostril in order to reapproximate the nasal mucosa, and the patient was then allowed to recover from anesthesia. The nasal tubes were removed in 24 hours. Operative Results
Neurodiagnostic Studies
The results of neurodiagnostic studies performed in these patients are shown in Table 2 . Abnormalities were visualized in 23 of 31 (74%) patients with routine skull x-ray films; 29 of 33 (88%) patients with hypocycloidal polytomes of the sella turcica; 15 of 18 (83%) cerebral angiograms; four of 14 (29%) pneumoencephalograms (PEG's); and 14 of 27 (52%) CT scans. In three of the 10 PEG's interpreted as normal, air was visualized in the sella turcica. In the four patients with normal polytomography, PEG and cerebral angiography were performed in two and three cases, respectively, and were normal in each instance. In these four cases, the decision to operate was based on clinical and endocrinological findings.
One of the more valuable studies for identifying abnormalities of the sella turcica, such as erosion or unilateral bulging, has been polytomography, and on the basis of our recent experience, the CT scan has been the most reliable test for determining para-and suprasellar extension of the tumor. In the early phase of this study as experience was being gained with CT scanners, cerebral angiography and/or PEG were employed more often than has been the case in the recent past. However, there is increasing use of CT scans in place of PEG and/or angiography in the diagnostic evaluation of pituitary tumors, and this trend is reflected in the fact that of 17 patients evaluated from November, 1976, through June, 1977, PEG was performed in none, angiography in only five, and CT scans in 14 cases. 
Clinical Findings
Preoperative data are shown in Table 3 . As expected, amenorrhea was the most common symptom in women, occurring in 21 (70%) of the 30 cases. Galactorrhea was present in 15 women. Headaches occurred in 12 patients (32%); the relatively low incidence was probably due to the fact that the majority of tumors were small (that is, < 1.0 cm in greatest diameter). Impairment in visual acuity and/or fields was present in nine (24%) of 37 cases.
The follow-up period ranged from 2 to 46 months. Following surgery, menses returned to normal in 10 of the 21 patients with amenorrhea. One of these patients has subsequently become pregnant and delivered normal twins. Galactorrhea ceased in 11 of 15 patients. In the nine patients with visual impairment (in acuity and/or visual fields), there was significant improvement in five, and no change in four patients. Vision was not made worse in any patient. Headache was either cured or significantly relieved in nine of 12 patients with this complaint.
Effect of Surgery on Elevated Levels of Serum Prolactin
Fasting basal prolactin levels above 25 ng/ml were considered abnormal. Also, the secretion of prolactin was considered inappropriate if there was less than a twofold increase in prolactin above fasting values during a 4-hour period following the intramuscular administration of 50 mg chlorpromazine. Based on the fasting preoperative prolactin values, the patients were divided into two groups: In Group I, fasting prolactin values ranged from 25 to 200 ng/ml, and in Group II, were greater than 200 ng/ml. The pre-and postoperative fasting values, response to chlorpromazine, and tumor size for both groups is shown in Table 4 .
In Group I, preoperative prolactin values ranged from 25 to 185 ng/ml, and the response to chlorpromazine was abnormal in every case. Ten days postoperatively, the basal level was below 25 ng/ml in 19 of the 26 patients. In four patients (Cases 7, 11, 13, and 17), the levels were above 25 ng/ml, but significantly below preoperative levels; in one patient (Case 12), there was no significant change and in two (Cases 10 and 14) the 10-day postoperative level was higher.
The prolactin levels in Group II ranged from 221 to 4000 ng/ml preoperatively. While the postoperative levels were all significantly less than preoperatively, the 10-day postoperative determinations in this group were less than 25 ng/ml in only three of the 11 patients.
All patients showed an inappropriate response to chlorpromazine before surgery. Postoperatively, the prolactin response to chlorpromazine returned to normal in three of the 26 patients in Group I and in none of the 11 in Group II.
Fasting prolactin levels 6 months after surgery have been obtained in 10 patients and are shown in Table 4 . In seven of the Group I patients, the 6-month level was lower in five (Cases 7, 12, 13, 14, and 17); higher in one (Case 11), and essentially unchanged in one (Case 19) as compared to the 10-day postoperative levels. In three patients in Group II, the prolactin level 6 months postoperatively showed a significant increase as compared to the 10-day postoperative levels.
While there was a suggestion that tumor size was related to preoperative basal prolactin levels, there was too much individual variation to identify a consistent trend. As shown in Table 4 , eight of 26 (37%) patients with tumors larger than 1.0 cm had fasting levels lower than 200 ng/ml, while four of 11 (36%) with tumors smaller than 1.0 cm had fasting levels higher than 200 ng/ml. As an example, Case 19 with a tumor smaller than 1.0 cm had a preoperative fasting prolactin level of 1345 ng/ml. *Group I = patients in whom preoperative fasting prolactin < 200 ng/ml; Group II = patients in whom preoperative fasting prolactin > 200 ng/ml. CPZ = chlorpromazine.
Preservation of Endocrine Function
Of the 37 cases, gross total tumor removal was accomplished in 35 and subtotal removal in two patients. Gross total removal means that all tumor tissue as visualized with the operating microscope was excised. The pituitary gland was identified and spared in 30 cases, not visualized in five, partially removed in one, and totally removed in one.
However, pre-and postoperative endocrinological evaluation provides a more accurate assessment than do gross observations of the status of pituitary function following transsphenoidal microsurgery in these patients.
Complete pre-and postoperative data (all tests listed in Table 1 ) were available in 26 of the 37 patients, thus permitting an evaluation of the effect of surgery on the pituitary- *Group A = patients in whom all preoperative studies were normal; Group B = patients in whom one or more preoperative endocrine deficiencies were present. -F = intact; -= impaired. target organ axes. Preoperatively, these cases were divided into two groups: Group A included patients in whom all preoperative pituitary-target organ axes were normal, and Group B included patients in whom one or more deficiencies were present (Table 5 ). In 12 of 13 cases in Group A, all pituitary-target organ axes were normal postoperatively, an indication that transsphenoidal microsurgical removal of a pituitary tumor can be accomplished in the majority of cases without damaging a functionally intact gland. Of 13 patients in Group B, five patients experienced no change in pituitary-target organ axes, six improved, and four suffered impairment in function as a result of surgery. Of the six patients in whom function returned (Cases 6, 8, 11, 15, 20, and 27) , the pituitary-thyroid axis was restored in two cases, the pituitaryadrenal in one, and the pituitary-gonadal in three. In the four cases with impairment caused by surgery (Cases 6, 20, 30, and 35), the pituitary-adrenal axis was involved in two, the pituitary-gonadal in one, and the pituitary-thyroid axis in one.
Only three patients (Cases 2, 10, and 15) have received postoperative radiation therapy. Conventional irradiation in a dosage ranging from 4500 to 5400 rads was delivered to each patient.
Complications
Immediate postoperative complications were relatively few and benign in nature. There were no deaths and no patient developed meningitis or cerebrospinal fluid rhinorrhea. Transient diabetes insipidus occurred in 22 patients postoperatively requiring from one to five doses of Pitressin Tannate in oil (vasopressin tannate) administered intramuscularly. Ten patients were further treated with clofibrate, a drug that has been found effective in treating partial diabetes insipidus; 2a eight of these patients subsequently have been able to discontinue the drug, and two patients still use it to control nocturia.
Discussion
Prolactin is a single-chain polypeptide trophic hormone secreted by the erythrosinophilic subtype of acidophilic cells in the adenohypophysis. 13 Its release into the systemic circulation is under dual control of hypothalamic neurohormones that act as releasing and inhibiting factors. 21 The predominant modulator is prolactin-inhibiting factor (PIF), which is required to prevent an unrestrained release of prolactin by the adenohypophysis. Thus, lesions such as pituitary stalk section or certain hypothalamic lesions that interfere with the normal delivery of PIF to the anterior lobe increase serum prolactin? 2,34 The prolactin inhibitory mechanism is dopaminergic in nature, r and there is some evidence to suggest that PIF is dopamine? 2 These physiological features serve as a basis for understanding both normal and abnormal responses of prolactin secretion to various pharmacological agents, and also explain some of the changes in prolactin secretion associated with pituitary tumors.
The physiology of prolactin is complex. The only established function of this hormone in humans is in the initiation and maintenance of lactation provided the glandular breast tissue has been appropriately primed by the interaction of several other hormones including estrogen, progestins, corticosteroids, and insulin. 7 While other functions of this hormone are not clear, the only clinical impairment resulting from elevated levels of serum prolactin in women is suppression or interference with the menstrual cycle resulting in amenorrhea and infertility, presumably due to an inhibitory effect on gonadotropin-releasing hormone. In men, impotence has been ascribed to elevated levels of prolactin, although this relationship is not established definitely. Spontaneous galactorrhea occurs in about 35% of women, TM and only rarely in men? Also, there is some concern over the long-term effect of hyperprolactinemia on glandular breast tissue, as experimental studies have suggested that prolactin is the important pituitary hormone facilitating mammary tumor growth in other species ?9 While several different conditions can cause hyperprolactinemia, in practice, the three most commonly identifiable are: ingestion of certain drugs, particularly phenothiazines; primary hypothyroidism; and pituitary tumors. 9,t8 Thus, in the diagnostic work-up of patients with hyperprolactinemia due to suspected pituitary tumors, it is essential to obtain a detailed history and to perform appropriate tests in order to identify the cause for the elevated serum prolactin.
The clinical significance of prolactin determination is that patients with pituitary tumors can thereby be identified, particularly those associated with fertility problems. The assay also affords a reliable means for following patients with prolactin:secreting pituitary tumors after treatment.
Elevated serum prolactin levels (> 25 ng/ml) in patients with pituitary tumors occur as a result of three mechanisms? ~ The first is straightforward and relates to the fact that certain tumors, either partly or entirely free of hypothalamic control, autonomously secrete excessive quantities of prolactin. Another possible mechanism is through impingement on the hypothalamus and/or stalk in such a manner as to diminish the secretion and delivery of PIF, thus resulting in unrestrained overproduction of prolactin by normal, non-tumorous cells in the adenohypophysis. A third mechanism is related to a primary disorder in the hypothalamus involving either diminished secretion of PIF or overproduction of prolactin-releasing factor, either of which act on the adenohypophysis to cause excessive prolactin secretion.
In patients with pituitary tumors, it is difficult to identify the underlying mechanism for elevated prolactin levels whenever the values are only moderately elevated (that is, < 100 ng/ml). Elevations of this magnitude in patients with pituitary tumors can result from compression of the stalk and/or hypothalamus as well as autonomous secretion by the tumor. Thus, a lesion such as an intrasellar craniopharyngioma, aneurysm, or a non-functional pituitary adenoma could cause modest elevations of prolactin. On the other hand, whenever the fasting level of prolactin exceeds I50 ng/ml, it almost certainly indicates that the mechanism for the elevated prolactin is autonomous secretion by a pituitary adenoma. While the prolactin response to chlorpromazine has been useful in identifying structural lesions in the vicinity of the stalk and gland, the test has not served to differentiate between the three mechanisms responsible for elevated prolactin levels in patients with pituitary tumors. The response (in serum prolactin levels) to chlorpromazine is blunted or negative in all three situations.
Elevated serum prolactin has also been observed in approximately 25% of patients with acromegaly. 1~ The associated hyperprolactinemia, which probably accounts for the reproductive defect in many acromegalic patients, is postulated to be caused by impingement on the hypothalamus and/or stalk by the adenoma. More rarely, tumors that secrete excessive quantities of both prolactin and growth hormone occur? 8 Pituitary tumors that autonomously secrete prolactin as their sole endocrine abnormality have been termed prolactinomas and have been estimated to account for approximately 70% of chromophobe adenomas. 11,~8 It has been claimed that serum prolactin levels may correlate with the size of the sella turcica as determined on lateral tomograms and may be higher in those with radiologically detectable tumors than in those with normal sella tomograms. ''~8 However, the data in the present study does not support this statement. The relationship between tumor size and preoperative basal prolactin levels (Table 4) was not consistent enough to identify a definite correlation between these two parameters. Currently, prolactinomas are the most frequently diagnosed functional pituitary tumors, and represent approximately 25% of all pituitary tumors. 25a7,2" As indicated by Hardy, TM these tumors are almost invariably located in the lateral aspect of the pituitary gland, which was true for all cases in the present series.
At first glance, the results of surgery in the present series of cases in restoring elevated prolactin levels to normal, particularly in those patients whose basal values exceeded 200 ng/ml, were somewhat disappointing.
Although the elevated values were significantly reduced following surgery, normal levels were not achieved in seven of 26 cases in Group I (preoperative basal level < 200 ng/ml) and in seven of 11 in Group II (preoperative basal level > 200 ng/ml). However, as gross total tumor removal appeared to be complete in 35 of 37 cases, we believe that it is unlikely that residual tumor fragments are responsible for the persistent elevation in prolactin values in all cases. A more plausible explanation is that the stalk was slightly damaged, resulting in interference with the normal delivery of PIF to the adenohypophysis. Lacking this inhibitory factor, an unrestrained release of prolactin from the normal gland results. Only long-term follow-up study will provide an answer as to which of these two explanations is correct. If the elevated prolactin levels continue to fall gradually or remain unchanged, the implication would be that the stalk was damaged and, in some cases, is gradually regenerating its capacity to deliver PIF. On the other hand, if the levels begin to increase, signifying tumor regrowth, it indicates that residual tumor fragment was responsible for the failure of prolactin to return to normal in the immediate postoperative period. Similar experience in failing to restore prolactin levels to normal was reported by Antunes, et aL, 1 who noted that prolactin levels returned to normal (< 25 mg/ml) in only eight of 20 patients undergoing transsphenoidal surgery for prolactin-secreting pituitary tumors. In reviewing the pre-and postoperative data reported by these workers, it is interesting to note that in 10 patients whose preoperative prolactin levels were > 200 ng/ml, none returned to normal postoperatively, while in 10 patients with prolactin levels < 200 ng/ml, eight showed restoration of normal levels following surgery. These findings are consistent with the postoperative results in our series.
Despite the surgeons' observations that all gross tumor was removed at surgery in 35 of 37 cases in this report, prolactin determinations in 10 cases 6 months postoperatively indicate that four patients have recurrent tumor. This finding emphasizes the fact that serial, periodic determination of prolactin is probably one of the most objective methods for determining tumor regrowth and will probably signal recurrence well in advance of either clinical or other endocrinological findings. Currently, the treatment of patients who show progressive postoperative elevations of prolactin but who are asymptomatic is not a settled issue.
The diagnostic work-up of a patient with suspected pituitary tumor associated with an abnormality in prolactin secretion has undergone considerable revision in recent years, particularly with the increased use of polytomography and the availability of CT scanners and radioimmunoassay methods for prolactin and other hormones. It thus seems appropriate to review the current diagnostic evaluation of these patients. We might consider for instance, which tests or other studies would be reasonable to obtain in a young woman with secondary amenorrhea with or without galactorrhea, elevated serum prolactin levels, and plain skull x-ray films that are either normal or show minimal enlargement of the sella turcica. The ingestion of drugs, particularly phenothiazines, should be excluded by careful history taking. A complete endocrine battery as outlined in Table 1 will exclude the possibility of hypothyroidism and will also determine whether the response of prolactin to administration of chlorpromazine is either normal or inappropriate. Complete baseline endocrine studies are also important in serving as a control to compare with posttreatment values to determine whether any endocrine axis was impaired (or improved) by the treatment. Anteroposterior and lateral hypocycloidal polytomography of the sella turcica is an essential part of the examination and will define small areas of erosion and/or asymmetry of the sella turcica, alterations in the clinoid processes, as well as other important alterations that may not be discernible on routine skull x-ray films.
ACT scan (both with and without contrast), which will detect most instances of extrasellar extension of tumor, should be a routine part of the diagnostic evaluation. In cases with a negative CT scan and no subjective impairment in vision, formal visual field and acuity testing by an ophthalmologist are not essential. Pneumoencephalography has been used in the past to determine the degree of suprasellar extension of the tumor, and also to exclude the diagnosis of the empty sella syndrome. In previous years, the demonstration by PEG of an empty sella syndrome indicated a non-surgical condition and usually concluded the diagnostic evaluation. Currently, however, the decision to proceed with pituitary surgery in these cases is based principally on clinical and endocrinological findings, especially baseline prolactin values and the response to chlorpromazine. Since the empty sella syndrome usually is not associated with an endocrinopathy a'l~ or clinical findings, it can be regarded as an incidental finding. Consequently, it is no longer essential to establish its presence or absence in order to make a decision regarding treatment. Thus, it is our opinion that PEG, except under unusual circumstances, is seldom indicated in the diagnostic evaluation of these patients. The question of cerebral angiography is more controversial. The primary purposes for performing this test would be to exclude an intrasellar aneurysm, to define suprasellar and parasellar extension of tumor, and to determine the position of the internal carotid arteries, especially if surgical treatment is to be performed via the transsphenoidal approach. Thus, whether to perform this test is a decision to be weighed by the physician managing a particular case. It is our opinion that angiography is probably unnecessary in the majority of cases, particularly in relatively young patients (under 40 years old) with small tumors. The symptomatic intrasellar aneurysm despite its potential for dramatic consequences during surgery is rare, and surgeons experienced in transsphenoidal surgery do not require to know the exact position of the internal carotid arteries before operation.
The complete role of the CT scan in the diagnostic evaluation of patients with pituitary tumors is yet to be defined. Its function is certain to be important, particularly in defining the extent of supra-and parasellar extension of these lesions, and it will probably replace more conventional diagnostic methods, namely, PEG and cerebral angiography, in this respect.
Considering the many advances in operative approaches, neuroradiological techniques, and endocrinological testing made in recent years, it is appropriate to review the current indications for surgery in pituitary tumors associated with abnormalities in prolactin secretion. While there appears to be little argument regarding the need for surgical management of pituitary tumors that compress neighboring structures, such as the optic chiasm, there remains a modicum of controversy over the small tumor associated with an abnormality in prolactin secretion. It is our opinion that except under unusual circumstances, surgery should be advised in all patients in whom a diagnosis of pituitary tumor has been made with reasonable certainty using currently available endocrinological, radiological and clinical criteria. In our experience, the decision to operate, particularly in patients with minimal findings, has been influenced strongly by the results of the chlorpromazine test for prolactin reserve. The mechanism for prolactin secretion appears to be very sensitive and easily disturbed; consequently, impairment of the normal response to chlorpromazine occurs with tumors as small as 4 to 5 mm in greatest diameter. Actually, the prolactin reserve test appears to be a more sensitive indicator of disturbed pituitary function than tests that directly measure pituitary-target organ axes, as evidenced by the fact that in the present study, 13 of the total number of patients preoperatively had normal pituitary-target organ axes, but in all patients of this group, some of whom had only borderline elevation of fasting prolactin, the response of prolactin to chlorpromazine administration was abnormal.
While many microadenomas may lie dormant or even possibly regress over a period of several years, some of these tumors will become aggressive and ultimately spread beyond the confines of the sella turcica. At present, there is no means available for predicting the ultimate biological behavior of these tumors. Any type of treatment at this late, advanced stage may fail to completely eradicate the tumor. Also, in patients with small prolactin-secreting tumors but otherwise normal pituitary function there is a good possibility that removal of the tumor while still small will restore a normal menstrual pattern without significant risk of damaging the normal but compromised gland.
The present series of cases emphasizes many of the advantages of the modern transsphenoidal microsurgical approach to pituitary tumors over other operative approaches such as craniotomy. The low incidence of complications and a negligible mortality rate represent major advantages of the procedure. 2,5,6,",xS,lv,z~,zT,aS,a7 In our series of cases, there were no deaths and the complications were relatively benign and not disabling. The transient nature of diabetes insipidus in the few patients who develop this problem is probably related to edema of the pituitary stalk incident to operative manipulation. The rare occurrence of CSF rhinorrhea is related to the fact that pituitary tumors are separated from the subarachnoid space by the diaphragma sellae-pseudocapsule of the tumor. Thus, it is possible to remove all gross-appearing tumor and spare this covering structure, thus preventing a CSF leak.
Another significant advantage of transsphenoidal surgery over other operative approaches is that gross total removal of the majority of tumors, even those lesions that extend significantly above the upper limits of the sella turcica, can be accomplished with preservation of the pituitary gland in the majority of the cases. Not only can pituitary function be maintained, but, as shown in the present study, certain hormonal functions may be restored following successful removal of the tumor by the transsphenoidal approach. In the authors' opinion, the ability to remove tumors and spare normal pituitary tissue with an operation that carries a low incidence of complications and rare mortality constitutes a major advance in pituitary tumor surgery.
The value of routine postoperative irradiation following transsphenoidal microsurgical "gross total" removal of a pituitary tumor is uncertain. In those cases where obvious tumor is left behind, it is our opinion that conventional radiotherapy should be used. However, whenever all gross-appearing tumor tissue is removed, then it seems proper not to use irradiation. Particularly in cases with a small hypersecreting tumor where all abnormal tissue is removed and the tumor bed treated with absolute alcohol, it would seem inappropriate to treat these patients with irradiation. Obviously, long-term follow-up study will be required to determine the best course ultimately to follow. Following craniotomy for pituitary tumors, Ray and Patterson 3~ had a recurrence rate of 8% in those who received postoperative irradiation and 22% in those who did not. Nevertheless, the authors state that the number of cases in their study was small, their study retrospective, and irradiation not without risk; therefore they recommend that postopera-Surgery of pituitary tumors with hyperprolactinemia tive irradiation might well be reserved for those in whom recurrence becomes evident or for those who have an invasive tumor at the first operation.
Proton-beam irradiation also has been used as primary therapy in functional pituitary tumors. In fact, until recently it was used extensively in the treatment of acromegaly. However, the major objection to irradiation therapy of any type, including proton beam, is the fact that there is a long delay from the time treatment is begun before a beneficial lowering of the abnormal hormone secretion occurs. When proton-beam therapy is used for treating pituitary tumors, there is also the potential danger of producing damage to the normal pituitary gland and to cranial nerves adjacent to the sella turcica. Moreover, very expensive equipment accessible to only a few institutions is required, and the method is not suitable for tumors that have suprasellar extensions. Regardless of how refined protonbeam therapy becomes, it cannot match the precision and completeness of identifying and removing tumor with sparing of the normal pituitary gland that can be accomplished with transsphenoidal microsurgery.
